Similar Items: Different SARS‐CoV‐2 Subvariants and Coagulation Markers Trend: A Retrospective Multicentric Study From Iranian Network for Research in Viral Diseases (INRVD)
- Evolution and viral properties of the SARS-CoV-2 BA.3.2 subvariant
- Respiratory Viral Co‐Infections in SARS‐CoV‐2 Positive Patients in Burkina Faso: A Cross‐Sectional Study
- Gastrointestinal Bleeding and Endoscopic Outcomes in Patients with SARS-CoV-2
- SARS‐CoV‐2 targets mitochondria, exacerbating COVID‐19 pneumonia
- Polymyalgia Rheumatica Post-SARS-CoV-2 Infection
- Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis